These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7724261)

  • 1. Clinical toxicology for the pediatrician.
    Woolf AD; Shannon MW
    Pediatr Clin North Am; 1995 Apr; 42(2):317-33. PubMed ID: 7724261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine testing for drugs of abuse: a survey of suburban parent-adolescent dyads.
    Schwartz RH; Silber TJ; Heyman RB; Sheridan MJ; Estabrook DM
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):158-61. PubMed ID: 12580685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should informed consent be required for laboratory testing for drugs of abuse in medical settings?
    Warner EA; Walker RM; Friedmann PD
    Am J Med; 2003 Jul; 115(1):54-8. PubMed ID: 12867235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interviewing guidelines for the clinical evaluation of adolescent substance abuse.
    Anglin TM
    Pediatr Clin North Am; 1987 Apr; 34(2):381-98. PubMed ID: 3550659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug of abuse screening in urine in emergency situations; useful or not?].
    De Wit LE; Dekker D
    Ned Tijdschr Geneeskd; 2021 Feb; 164():. PubMed ID: 33651500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for drugs of abuse in children and adolescents. American Academy of Pediatrics Committee on Substance Abuse.
    Pediatrics; 1996 Aug; 98(2 Pt 1):305-7. PubMed ID: 8692638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Benefits of Direct-to-Definitive Testing for Monitoring Compliance in Pain Management.
    Gencheva R; Petrides A; Kantartjis M; Tanasijevic M; Dahlin JL; Melanson S
    Pain Physician; 2018 Nov; 21(6):E583-E592. PubMed ID: 30508989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse.
    Kulig JW;
    Pediatrics; 2005 Mar; 115(3):816-21. PubMed ID: 15741395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical analysis of toxic substances useful for clinical toxicology--9--barbiturate].
    Komiyama Y; Hori Y; Namera A; Kuroki Y
    Chudoku Kenkyu; 2004 Jan; 17(1):79-84. PubMed ID: 15079929
    [No Abstract]   [Full Text] [Related]  

  • 12. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse screening in adolescents.
    DelRosario G; Kahle L; Lewis K; Lepper LT
    JAAPA; 2017 Nov; 30(11):52-53. PubMed ID: 29064941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology in Addiction Medicine.
    Schwarz DA; George MP; Bluth MH
    Clin Lab Med; 2016 Dec; 36(4):685-692. PubMed ID: 27842786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a rapid bedside toxicology screen in patients suspected of drug toxicity.
    Tomaszewski C; Runge J; Gibbs M; Colucciello S; Price M
    J Emerg Med; 2005 May; 28(4):389-94. PubMed ID: 15837018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An investigation of drug abuse and the utility of toxicology screening for use in emergency centers].
    Inuzuka S; Hayashida M; Nihira M
    Nihon Ika Daigaku Zasshi; 1997 Aug; 64(4):344-52. PubMed ID: 9283205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Academy of Pediatrics Committee on Adolescence, Committee on Bioethics, and Provisional Committee on Substance Abuse: Screening for drugs of abuse in children and adolescents.
    Pediatrics; 1989 Aug; 84(2):396-8. PubMed ID: 2748275
    [No Abstract]   [Full Text] [Related]  

  • 20. Best practice in substance misuse.
    Taylor AL
    Arch Dis Child Educ Pract Ed; 2012 Aug; 97(4):143-51. PubMed ID: 22374690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.